Loading…

Binding and Functional Properties of Recombinant and Endogenous CXCR3 Chemokine Receptors

IP10 and MIG are two members of the CXC branch of the chemokine superfamily whose expression is dramatically up-regulated by interferon (IFN)-γ. The proteins act largely on natural killer (NK)-cells and activated T-cells and have been implicated in mediating some of the effects of IFN-γ and lipopo...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 1998-07, Vol.273 (29), p.18288-18291
Main Authors: Weng, Y, Siciliano, S J, Waldburger, K E, Sirotina-Meisher, A, Staruch, M J, Daugherty, B L, Gould, S L, Springer, M S, DeMartino, J A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IP10 and MIG are two members of the CXC branch of the chemokine superfamily whose expression is dramatically up-regulated by interferon (IFN)-γ. The proteins act largely on natural killer (NK)-cells and activated T-cells and have been implicated in mediating some of the effects of IFN-γ and lipopolysaccharides (LPSs), as well as T-cell-dependent anti-tumor responses. Recently both chemokines have been shown to be functional agonists of the same G-protein-coupled receptor, CXCR3. We now report the pharmacological characterization of CXCR3 and find that, when heterologously expressed, CXCR3 binds IP10 and MIG with K i values of 0.14 and 4.9 n m , respectively. The receptor has very modest affinity for SDF-1α and little or no affinity for other CXC-chemokines. The properties of the endogenous receptor expressed on activated T-cells are similar. Surprisingly, several CC-chemokines, particularly eotaxin and MCP-4, also compete with moderate affinity for the binding of IP10 to CXCR3. Eotaxin does not activate CXCR3 but, in CXCR3-transfected cells, can block IP10-mediated receptor activation. Eotaxin, therefore, may be a natural CXCR3 antagonist.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.273.29.18288